Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Debt Ratio: 2016-2018

  • Niagen Bioscience's Debt Ratio fell 34.36% to 0.00 in Q4 2018 from the same period last year, while for Dec 2018 it was 0.00, marking a year-over-year decrease of 34.36%. This contributed to the annual value of 0.00 for FY2018, which is 34.36% down from last year.
  • Latest data reveals that Niagen Bioscience reported Debt Ratio of 0.00 as of Q4 2018, which was down 34.36% from 0.00 recorded in Q4 2017.
  • In the past 5 years, Niagen Bioscience's Debt Ratio ranged from a high of 0.26 in Q1 2016 and a low of 0.00 during Q4 2018.
  • For the 3-year period, Niagen Bioscience's Debt Ratio averaged around 0.07, with its median value being 0.01 (2017).
  • Data for Niagen Bioscience's Debt Ratio shows a maximum YoY tumbled of 93.30% (in 2016) over the last 5 years.
  • Over the past 3 years, Niagen Bioscience's Debt Ratio (Quarterly) stood at 0.02 in 2016, then plummeted by 71.62% to 0.00 in 2017, then plummeted by 34.36% to 0.00 in 2018.
  • Its last three reported values are 0.00 in Q4 2018, 0.00 for Q4 2017, and 0.02 during Q4 2016.